{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:32Z","timestamp":1772121692280,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.transci.2021.103237","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T14:03:29Z","timestamp":1629209009000},"page":"103237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients"],"prefix":"10.1016","volume":"60","author":[{"given":"Tu\u011f\u00e7e Nur","family":"Yi\u011feno\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-9245","authenticated-orcid":false,"given":"Semih","family":"Ba\u015fc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turgay","family":"Ula\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sinan","family":"Dal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdal","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba","family":"Hac\u0131bekiro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Namdaro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali","family":"Erkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burhan","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Altunta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103237_bib0005","series-title":"Current topics in microbiology and immunology \/ ergebnisse der mikrobiologie und immunit\u00e4tsforschung","first-page":"87","article-title":"Coronaviruses: a comparative review","author":"McIntosh","year":"1974"},{"key":"10.1016\/j.transci.2021.103237_bib0010","series-title":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","author":"WHO","year":"2003"},{"issue":"1","key":"10.1016\/j.transci.2021.103237_bib0015","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2019.006","article-title":"Respiratory viral infections in children and adolescents with hematological malignancies","volume":"11","author":"Han","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.transci.2021.103237_bib0020","unstructured":"Middle East respiratory syndrome coronavirus (MERS-CoV). World Health Organization. Retrieved 10 April 2017."},{"issue":"October","key":"10.1016\/j.transci.2021.103237_bib0025","article-title":"The outcome of COVID-19 in patients with hematological malignancy","author":"Yigenoglu","year":"2020","journal-title":"J Med Virol"},{"issue":"7","key":"10.1016\/j.transci.2021.103237_bib0030","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1177\/1078155220953198","article-title":"Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors","volume":"26","author":"Ba\u015fc\u0131","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.transci.2021.103237_bib0035","unstructured":"World Health Organization Press Conference. The World Health Organization (WHO) Has Officially Named the Disease Caused by the Novel Coronavirus as COVID-19. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 [Accessed 15 May 2021]."},{"issue":"Apr. (2)","key":"10.1016\/j.transci.2021.103237_bib0040","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"issue":"10223","key":"10.1016\/j.transci.2021.103237_bib0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10229","key":"10.1016\/j.transci.2021.103237_bib0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2021.103237_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100019","article-title":"Mesenchymal stem cells and management of COVID-19 pneumonia","volume":"5","author":"Metcalfe","year":"2020","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.transci.2021.103237_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102940","article-title":"An overview of current position on cell therapy in transfusion science and medicine: from fictional promises to factual and perspectives from red cell substitution to stem cell therapy","author":"Lanza","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103237_bib0070","first-page":"71","article-title":"Existence of reserve quiescent stem cells in adults, from amphibians to humans","volume":"280","author":"Young","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.transci.2021.103237_bib0075","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bone.2006.02.061","article-title":"Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells","volume":"39","author":"D\u2019Ippolito","year":"2006","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.transci.2021.103237_bib0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.transci.2021.103237_bib0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/14653240410005366-1","article-title":"Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta","volume":"6","author":"Igura","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.transci.2021.103237_bib0090","series-title":"Principles of regenerative medicine","first-page":"205","article-title":"Chapter 14 - mesenchymal stem cells","author":"Gazit","year":"2019"},{"key":"10.1016\/j.transci.2021.103237_bib0095","series-title":"Principles of regenerative medicine","first-page":"219","article-title":"Chapter 15 - mesenchymal stem cells in regenerative medicine","author":"Caplan","year":"2019"},{"key":"10.1016\/j.transci.2021.103237_bib0100","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1159\/000447857","article-title":"Application of bone marrow-derived mesenchymal stem cells in the treatment of intrauterine adhesions in rats","volume":"39","author":"Wang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.transci.2021.103237_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096662","article-title":"Bone marrow-derived stem cell (BMDSC) transplantation improves fertility in a murine model of asherman\u2019s syndrome","volume":"9","author":"Alawadhi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2021.103237_bib0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopha.2018.03.091","article-title":"Stem cell therapy in asherman syndrome and thin endometrium: stem cell-based therapy","volume":"102","author":"Azizi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.transci.2021.103237_bib0115","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/ndt\/gfs168","article-title":"Therapeutic potential of mesenchymal stem cell-derived microvesicles","volume":"27","author":"Biancone","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transci.2021.103237_bib0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bpobgyn.2015.07.006","article-title":"Mesenchymal stem cells from wharton\u2019s jelly and amniotic fluid","volume":"31","author":"Joerger-Messerli","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.transci.2021.103237_bib0125","series-title":"Bioprocess development for human mesenchymal stem cell therapy products, new advances on fermentation processes, Rosa mar\u00eda Mart\u00ednez-Espinosa","author":"Barekzai","year":"2019"},{"issue":"6","key":"10.1016\/j.transci.2021.103237_bib0130","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.transci.2021.103237_bib0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.transci.2021.103237_bib0140","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4236973","article-title":"Mesenchymal stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives","volume":"2019","author":"Harrell","year":"2019","journal-title":"Stem Cells Int"},{"issue":"4","key":"10.1016\/j.transci.2021.103237_bib0145","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2021.103237_bib0150","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","article-title":"MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2","volume":"113","author":"Spaggiari","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.transci.2021.103237_bib0155","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/657625","article-title":"Some basic aspects of HLA-G biology","volume":"2014","author":"Alegre","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.transci.2021.103237_bib0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2161-0991.1000e127","article-title":"Immunosupressive properties of hla-g molecules produced by mesenchymal stromal cells","volume":"3","author":"Rizzo","year":"2013","journal-title":"J Transplant Technol Res"},{"key":"10.1016\/j.transci.2021.103237_bib0165","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pbio.0040009","article-title":"Activation of NK cells by an endocytosed receptor for soluble HLA-G","volume":"4","author":"Rajagopalan","year":"2006","journal-title":"PLoS Biol"},{"key":"10.1016\/j.transci.2021.103237_bib0170","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s10815-007-9148-3","article-title":"HLA-G and its role in implantation (review)","volume":"24","author":"Roussev","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.transci.2021.103237_bib0175","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1128","article-title":"Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence","volume":"9","author":"Zhang","year":"2020","journal-title":"Clin Transl Immunol"},{"issue":"Dec. (12)","key":"10.1016\/j.transci.2021.103237_bib0180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.humimm.2020.10.001","article-title":"Puzzling out the COVID-19: therapy targeting HLA-G and HLA-E","volume":"81","author":"Zidi","year":"2020","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0185","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol Lett"},{"issue":"Aug. (4)","key":"10.1016\/j.transci.2021.103237_bib0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/scrt486","article-title":"The ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p","volume":"5","author":"Lien","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.transci.2021.103237_bib0195","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/CCM.0b013e31823bc89a","article-title":"Systemic human orbital fat-derived stem\/stromal cell transplantation ameliorates acute inflammation in lipopolysaccharide-induced acute lung injury","volume":"40","author":"Chien","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.transci.2021.103237_bib0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.transci.2021.103237_bib0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17476348.2020.1679628","article-title":"The potential of mesenchymal stem cell therapy for chronic lung disease","volume":"14","author":"Cruz","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.transci.2021.103237_bib0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/qjmed\/hcw001","article-title":"A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema","volume":"109","author":"Stolk","year":"2016","journal-title":"QJM"},{"key":"10.1016\/j.transci.2021.103237_bib0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12890-015-0061-8","article-title":"Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis","volume":"15","author":"Morales","year":"2015","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.transci.2021.103237_bib0220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000347072","article-title":"Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome","volume":"85","author":"Cardenes","year":"2013","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"19","key":"10.1016\/j.transci.2021.103237_bib0230","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"issue":"Jul. (1)","key":"10.1016\/j.transci.2021.103237_bib0235","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.transci.2021.103237_bib0240","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","volume":"75","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.transci.2021.103237_bib0245","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3906\/sag-2004-145","article-title":"Antiviral treatment of COVID-19","volume":"50","author":"Yav\u0131z","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.transci.2021.103237_bib0250","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2021.103237_bib0255","series-title":"Coronavirus (COVID-19) update: FDA revokes emergency use authorization for monoclonal antibody bamlanivimab. News release","year":"2021"},{"key":"10.1016\/j.transci.2021.103237_bib0260","article-title":"Trends and Targets in various types stem cells derived transfusable RBC substitution therapy: obstacals that need to be converted to opportunity","volume":"6","author":"Lanza","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.transci.2021.103237_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(15)00224-0","article-title":"Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis","volume":"3","author":"Hashmi","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.transci.2021.103237_bib0270","first-page":"A46","article-title":"CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study","volume":"5","author":"Kamen","year":"2018","journal-title":"Lupus Sci Med"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.transci.2021.103237_bib0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.transci.2021.103237_bib0285","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021429","article-title":"Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: a case report","volume":"99","author":"Liang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.transci.2021.103237_bib0290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","article-title":"Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells","volume":"11","author":"Shu","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"172","key":"10.1016\/j.transci.2021.103237_bib0295","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial","volume":"5","author":"Meng","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.transci.2021.103237_bib0300","series-title":"Stem cell and exosome products","author":"Centers for Disease Control and Prevention","year":"2019"},{"issue":"7","key":"10.1016\/j.transci.2021.103237_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"10229","key":"10.1016\/j.transci.2021.103237_bib0310","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0315","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1532\/IJH97.03167","article-title":"Tissue factor: a key molecule in hemostatic and nonhemostatic systems","volume":"79","author":"Morrissey","year":"2004","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.transci.2021.103237_bib0320","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S2352-3026(20)30109-5","article-title":"Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19","volume":"7","author":"Wang","year":"2020","journal-title":"Lancet Haematol"},{"issue":"17","key":"10.1016\/j.transci.2021.103237_bib0325","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molmed.2018.12.006","article-title":"Intravascular mesenchymal stromal\/stem cell therapy product diversification: time for new clinical guidelines","volume":"25","author":"Moll","year":"2019","journal-title":"Trends Mol Med"},{"issue":"8","key":"10.1016\/j.transci.2021.103237_bib0335","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/sctm.18-0260","article-title":"Human adipose-derived mesenchymal stem cells modify lung immunity and improve antibacterial defense in pneumosepsis caused by Klebsiella pneumoniae","volume":"8","author":"Perlee","year":"2019","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0340","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbrc.2012.12.134","article-title":"Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism","volume":"431","author":"Tatsumi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.transci.2021.103237_bib0345","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.transproceed.2017.03.078","article-title":"Thromboembolism induced by umbilical cord mesenchymal stem cell infusion: a report of two cases and literature review","volume":"49","author":"Wu","year":"2017","journal-title":"Transplant Proc"},{"issue":"13","key":"10.1016\/j.transci.2021.103237_bib0350","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","article-title":"Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation","volume":"69","author":"R\u00f8sland","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.transci.2021.103237_bib0355","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","article-title":"Sarcoma derived from cultured mesenchymal stem cells","volume":"25","author":"Tolar","year":"2007","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.transci.2021.103237_bib0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2021.103237_bib0365","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00277-012-1500-8","article-title":"Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders","volume":"91","author":"Campioni","year":"2012","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.transci.2021.103237_bib0370","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10561-014-9420-6","article-title":"Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium","volume":"15","author":"Chen","year":"2014","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.transci.2021.103237_bib0375","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat2189","article-title":"Challenges for mesenchymal stromal cell therapies 2019","volume":"11","author":"Martin","year":"2019","journal-title":"Sci Transl Med"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:53:01Z","timestamp":1761468781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221002299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1473050221002299"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103237","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/HMFDHN","asserted-by":"object"}]},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103237"}}